Faculty Opinions recommendation of Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Keyword(s):
Phase Ii
◽
2018 ◽
Vol 45
(3)
◽
pp. 671-678
◽
2009 ◽
Vol 39
(10)
◽
pp. 638-643
◽
2009 ◽
Vol 39
(10)
◽
pp. 686-689
◽
2011 ◽
Vol 16
(4)
◽
pp. 379-386
◽